Clinical Testing News and Research

RSS
New class of sleeping pill preserves ability to wake in response to danger signals

New class of sleeping pill preserves ability to wake in response to danger signals

Microbial metabolite from pomegranates can reduce and protect against IBD

Microbial metabolite from pomegranates can reduce and protect against IBD

New molecular engineering method improves precision of biomarker analysis

New molecular engineering method improves precision of biomarker analysis

New therapy for childhood blindness shows 'very promising' results

New therapy for childhood blindness shows 'very promising' results

New genetic testing method increases the precision of biomarker analysis

New genetic testing method increases the precision of biomarker analysis

Researchers identify potential target for new breast cancer treatments

Researchers identify potential target for new breast cancer treatments

Home-based pulmonary function monitoring for teens with Duchenne muscular dystrophy

Home-based pulmonary function monitoring for teens with Duchenne muscular dystrophy

Surprising discovery about BH4 may rekindle interest in once-promising pathway

Surprising discovery about BH4 may rekindle interest in once-promising pathway

Miniature pacemakers aim to make heart procedures for infants less invasive, more efficient

Miniature pacemakers aim to make heart procedures for infants less invasive, more efficient

Researchers examine immune responses to CRISPR-Cas9 gene editing system

Researchers examine immune responses to CRISPR-Cas9 gene editing system

Researchers awarded grant to advance testing of experimental heroin vaccine

Researchers awarded grant to advance testing of experimental heroin vaccine

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

New drug to treat Parkinson's disease psychosis do not pose greater risk of death

New drug to treat Parkinson's disease psychosis do not pose greater risk of death

New approach for bone marrow transplant could make it safer and more effective for patients

New approach for bone marrow transplant could make it safer and more effective for patients

Blood, sweat and workplace wellness: Where to draw the line on incentives

Blood, sweat and workplace wellness: Where to draw the line on incentives

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma